Insulin startup Thermalin Diabetes has earned itself an esteemed new partner in its quest to develop formulations of insulin that will give people with diabetes tighter control over their blood sugar levels. Cleveland-based Thermalin said today that JDRF will provide it with up to $1 million for specific milestones related to identifying a clinical candidate […]
The infusion or “smart” pumps market will grow more than a billion dollars from its 2012 value–$3.17 billion–to its 2019 worth–$4.26 billion, according to a report from Frost & Sullivan. Even taking reimbursement issues into account, ambulatory and insulin pumps should see significant growth over the next several years, according to new research from Frost […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Boston Children’s Hospital stirred up some buzz this week when it said its researchers had made a breakthrough that could change the face of diabetes treatment. On its Vector blog, the hospital called attention to a study published earlier this year in the journal Diabetes that identified a certain pathway in the body as the […]
Thanks to a new three-year, $1 million grant, a group of researchers at Case Western Reserve University are continuing to develop and test a form of glucose-responsive insulin that may someday be able to reduce the risk of dangerous hypoglycemic episodes in people with type 1 diabetes. The insulin is being developed in the lab […]